Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.89 USD | -0.53% | -10.43% | -16.00% |
Mar. 29 | TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 06 | Knight Therapeutics Announces Launch of Bijuva in Canada | MT |
Financials (USD)
Sales 2022 | 69.96M | Sales 2023 | 1.3M | Capitalization | 25.77M |
---|---|---|---|---|---|
Net income 2022 | 112M | Net income 2023 | -10M | EV / Sales 2022 | 0.34 x |
Net cash position 2022 | 29.31M | Net Debt 2023 | 3.68M | EV / Sales 2023 | 22.6 x |
P/E ratio 2022 |
0.47
x | P/E ratio 2023 |
-2.28
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.22% |
1 day | -0.53% | ||
1 week | -10.43% | ||
Current month | -17.47% | ||
1 month | -17.83% | ||
3 months | -17.11% | ||
6 months | -26.46% | ||
Current year | -16.00% |
Managers | Title | Age | Since |
---|---|---|---|
Marlan Walker
CEO | Chief Executive Officer | 50 | 13-05-31 |
Joseph Ziegler
DFI | Director of Finance/CFO | - | 23-08-16 |
Corporate Officer/Principal | - | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tommy Thompson
CHM | Chairman | 81 | 12-04-15 |
Cooper Collins
BRD | Director/Board Member | 45 | 12-02-27 |
Gail Naughton
BRD | Director/Board Member | 69 | 20-03-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-16 | 1.9 | -2.56% | 45,679 |
24-04-15 | 1.95 | -2.01% | 38,139 |
24-04-12 | 1.99 | -4.33% | 32,038 |
24-04-11 | 2.08 | -1.42% | 28,125 |
24-04-10 | 2.11 | -1.86% | 19,434 |
Delayed Quote Nasdaq, April 17, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-16.00% | 21.91M | |
+2.15% | 69.82B | |
+10.70% | 9.2B | |
-19.62% | 4.59B | |
+24.23% | 3.83B | |
-0.44% | 3.71B | |
+30.89% | 2.59B | |
-25.01% | 2.3B | |
-28.30% | 2.09B | |
+1.33% | 1.83B |
- Stock Market
- Equities
- TXMD Stock